Cart
sales@molnova.com
CP-060
CAS No. 180090-15-7
CP-060( —— )
Catalog No. M32859 CAS No. 180090-15-7
CP-060 is a potent Ca2+ antagonist and inhibits Ca2+ overload with antioxidant and cardioprotective activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 642 | In Stock |
|
| 5MG | 473 | In Stock |
|
| 10MG | 638 | In Stock |
|
| 25MG | 950 | In Stock |
|
| 50MG | 1256 | In Stock |
|
| 100MG | 1693 | In Stock |
|
| 200MG | 2288 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCP-060
-
NoteResearch use only, not for human use.
-
Brief DescriptionCP-060 is a potent Ca2+ antagonist and inhibits Ca2+ overload with antioxidant and cardioprotective activities.
-
DescriptionCP- 060 is a potent Ca2+ antagonist, inhibits Ca2+ overload and possesses antioxidant and cardioprotective activities.
-
In VitroCP-?060 (0.5, 5 μM) inhibits rabbit LDL oxidation induced by soybean lipoxygenase by 12.9% and 3.0%, respectively.
-
In VivoCP-?060 (100 mg/kg, i.v.) increases the coronary blood flow by 96% in anesthetized dogs.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number180090-15-7
-
Formula Weight542.73
-
Molecular FormulaC30H42N2O5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CCN(CCOC=1C=C2C(=CC1)OCO2)C)N3C(C4=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C4)SCC3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kato T, et al. Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3, 5-di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones. J Med Chem. 1998 Oct 22;41(22):4309-16.?
molnova catalog
related products
-
CALP3
Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site. Activates phosphodiesterase in the absence of Ca2+ and inhibits Ca2+-mediated cytotoxicity and apoptosis (IC50 = 33 μM).
-
O-1602
O-1602 is a novel GPR55 agonist, an atypical cannabinoid associated with the central nervous system and obesity, and is a candidate compound for the treatment of cystitis.
-
(S)-crizotinib
(S)-crizotinib（IC50 of 72 nM）, an effective MTH1 (NUDT1) inhibitor, is the (S)-enantiomer of crizotinib.
